MS Trial Alert: Investigators Studying ELND002, Subcutaneous Drug in 125 People with Relapsing MS http://ow.ly/2SgPl
Call Us 604-733-4007 | Toll Free 1-855-484-5859
MS Trial Alert: Investigators Studying ELND002, Subcutaneous Drug in 125 People with Relapsing MS http://ow.ly/2SgPl